These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP. Muradov H; Boyd KK; Artemyev NO Vision Res; 2004; 44(21):2437-44. PubMed ID: 15358079 [TBL] [Abstract][Full Text] [Related]
3. Cyclic guanosine 5'-monophosphate binding to regulatory GAF domains of photoreceptor phosphodiesterase. Cote RH Methods Mol Biol; 2005; 307():141-54. PubMed ID: 15988061 [TBL] [Abstract][Full Text] [Related]
4. Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5. Sopory S; Balaji S; Srinivasan N; Visweswariah SS FEBS Lett; 2003 Mar; 539(1-3):161-6. PubMed ID: 12650945 [TBL] [Abstract][Full Text] [Related]
5. Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5. Granovsky AE; Artemyev NO J Biol Chem; 2001 Jun; 276(24):21698-703. PubMed ID: 11285263 [TBL] [Abstract][Full Text] [Related]
6. Probing domain functions of chimeric PDE6alpha'/PDE5 cGMP-phosphodiesterase. Granovsky AE; Natochin M; McEntaffer RL; Haik TL; Francis SH; Corbin JD; Artemyev NO J Biol Chem; 1998 Sep; 273(38):24485-90. PubMed ID: 9733741 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Soderling SH; Bayuga SJ; Beavo JA Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840 [TBL] [Abstract][Full Text] [Related]
8. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Martinez SE; Wu AY; Glavas NA; Tang XB; Turley S; Hol WG; Beavo JA Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13260-5. PubMed ID: 12271124 [TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A. Wu AY; Tang XB; Martinez SE; Ikeda K; Beavo JA J Biol Chem; 2004 Sep; 279(36):37928-38. PubMed ID: 15210692 [TBL] [Abstract][Full Text] [Related]
10. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity. Turko IV; Francis SH; Corbin JD Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742 [TBL] [Abstract][Full Text] [Related]
11. The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change. Martinez SE; Heikaus CC; Klevit RE; Beavo JA J Biol Chem; 2008 Sep; 283(38):25913-9. PubMed ID: 18614542 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5. Cote RH Int J Impot Res; 2004 Jun; 16 Suppl 1():S28-33. PubMed ID: 15224133 [TBL] [Abstract][Full Text] [Related]
13. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648 [TBL] [Abstract][Full Text] [Related]
14. The glutamic acid-rich protein-2 (GARP2) is a high affinity rod photoreceptor phosphodiesterase (PDE6)-binding protein that modulates its catalytic properties. Pentia DC; Hosier S; Cote RH J Biol Chem; 2006 Mar; 281(9):5500-5. PubMed ID: 16407240 [TBL] [Abstract][Full Text] [Related]
15. The gamma subunit of the rod photoreceptor cGMP phosphodiesterase can modulate the proteolysis of two cGMP binding cGMP-specific phosphodiesterases (PDE6 and PDE5) by caspase-3. Frame M; Wan KF; Tate R; Vandenabeele P; Pyne NJ Cell Signal; 2001 Oct; 13(10):735-41. PubMed ID: 11602184 [TBL] [Abstract][Full Text] [Related]
16. The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory gamma subunit. Mou H; Cote RH J Biol Chem; 2001 Jul; 276(29):27527-34. PubMed ID: 11375400 [TBL] [Abstract][Full Text] [Related]
17. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization. Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB J Biol Chem; 1998 Jun; 273(25):15559-64. PubMed ID: 9624146 [TBL] [Abstract][Full Text] [Related]